Filter
1

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Halifax, Farmington CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness

for
Persian Gulf Syndrome, Gulf War Syndrome,
Location: Tampa FL, Dallas TX, Los Angeles CA
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06716411

Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

for
Multiple Myeloma, Secondary Immunodeficiency
Location: Albany NY, Montreal, Baltimore MD, Detroit MI,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06980480

Phase3, Recruiting

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

for
Multiple Myeloma
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07225738

Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

for
Multiple Myeloma (MM)
Location: New York NY, Brooklyn NY, Baltimore MD, Durham NC,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07280013

Phase1, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

for
Extramedullary Disease in Multiple Myeloma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06627751

Phase2, Recruiting

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

for
Lymphoma, Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT07226934

Recruiting

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapse Multiple Myeloma, Refractory Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT07093554

Phase1, Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

for
Deep Vein Thrombosis (DVT),
Location: Fort Lauderdale FL, Tampa FL, Edgewood KY, Plano TX
Sponsor: Argon Medical Devices

Sex: All

Age: 18+

Code: NCT07102160

Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

for
Multiple Myeloma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06251076

Recruiting

Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions

for
Multiple Chronic Conditions, Social Needs, Care Gaps,
Location: Pleasanton CA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT06941519

Recruiting

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

for
Multiple Myeloma Refractory, Relapsed Multiple Myeloma
Location: Quebec, Levis
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 18+

Code: NCT07094048

Recruiting

Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis

for
Children With Medical Complexity (CMC),
Location: Salt Lake City UT, Los Angeles CA
Sponsor: University of Utah

Sex: All

Age: 8+

Code: NCT07167927

Recruiting

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

for
Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07188090

Phase2, Recruiting

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

for
Multiple Myeloma
Location: Cleveland OH, San Francisco CA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07149857

Phase2, Recruiting

A Dietary Study for People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07226609

Recruiting

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07101445

Recruiting

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06517017

Phase2, Recruiting

A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses

for
Multiple Actinic Keratoses
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06851507

Phase3, Recruiting

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

for
Multiple System Atrophy
Location: New York NY, Boca Raton FL, Pittsburgh PA, Tampa FL,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 30+

Code: NCT07197866

Phase2, Recruiting